|
|
Volumn 354, Issue 7, 2006, Pages 767-768
|
|
Screening and breast cancer [8]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADJUVANT THERAPY;
BREAST CANCER;
CANCER DIAGNOSIS;
CANCER MORTALITY;
CANCER RISK;
CANCER SCREENING;
CANCER STAGING;
CANCER SURVIVAL;
HUMAN;
LETTER;
LYMPH NODE;
POPULATION;
PRIORITY JOURNAL;
TUMOR VOLUME;
ADJUVANT CHEMOTHERAPY;
BREAST TUMOR;
MAMMOGRAPHY;
MASS SCREENING;
MORTALITY;
NOTE;
RADIOGRAPHY;
UNITED STATES;
ADULT;
FEMALE;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
SURVIVAL;
TUMOR RECURRENCE;
STATISTICAL MODEL;
RISK REDUCTION;
EPIDEMIOLOGY;
ANTINEOPLASTIC AGENT;
TAMOXIFEN;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
HUMANS;
MAMMOGRAPHY;
MASS SCREENING;
TAMOXIFEN;
UNITED STATES;
ADULT;
FEMALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASM RECURRENCE, LOCAL;
SURVIVAL ANALYSIS;
MODELS, STATISTICAL;
RISK REDUCTION BEHAVIOR;
BIAS (EPIDEMIOLOGY);
|
|
EID: 32644480628
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMc053256 Document Type: Letter |
|
Times cited : (4)
|
|
References (2)
|
